Meanwhile, we found that SPAG5 expression was increased in HER2 positive, poor differentiated, lymph node positive and TP53 mutated breast cancer subtypes all of which were strongly associated with tumor progression. This evidence concerns the gene ERBB2 and breast carcinoma.